A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Condition: Chondrosarcoma Interventions: Drug: Anlotinib hydrochloride; Drug: PD-1 inhibitor Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials